1Regar E,Sianos G,Serruys P M. Stent development and local drug delivery Bri Med Bull, 2001,59: 227
2Brasen J H, Kivela A, Roser K, et al. Angiogenesis,vascular endothelial growth factor and platelet-derived growth factor-BB expression. iron deposition. and oxidation-specific epitopes in stented human coronary arteries. Aterioscler Thromb Vasc Biol, 2001,21:1720
3Farb A,Sangiorgi G,Carter A J,et al. Pathology of acute and chronic coronary stenting in humans. Circulation,1999,99:44
4Angioi M, Abdelmouttaleb L, Rodriguez R M, et al.Increased C-reactive protein levels in patients with in stent restenosis and its implications. AM J Cardiol,2001,87:1189
5Ridker P M, Rifai N, Lowenthal S P, et al. Rapid reduction in c-reactive protein with Cerivastatin among 785 patients with primary hypercholesterolemia.Circulation, 2001,103:1191
6Amoroso G, van Veldhuisen D J, Tio R A, et al.Pathophysiology of vascular endothelium and circulating platelets : implications for coronary revascularisation and treatment. Int J Cardiol, 2001,79:265
7Takemoto M,Liao J k. Pleiotropic effects of 3-hydroxy-3methylglutaryl coenzyme a reductase inhibitors.Arterioscler Thromb Vasc Biol, 2001,21 : 1712
8Lefer A M,Scalia R,Lefer D,et al. Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowing: new concepts for cardiovascular disease. Cardiovasc Res, 2001,49: 281
9Vincent L. Chen W M, Hong L, et al. Inhibition of endothelial Cell migration by cerivastain,an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect . Elsevier Sci BV, 2001,495
10Christen T, Verin V, Bochaton-Piallat ML, et al.Mechanism of neointima formation an remodeling in the Porcin coronary artery. Circulation, 2001,103: 882
2Maisel A, Cesario D, Baird S, et al. Experimental autoimmune myocarditis produced by adoptive transfer of splenocytes after myocardial infarction[J]. Circ Res, 1998, 82 (4) :458.
3Cleutjens J P, Creemers E E. Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction [J].Card Fail, 2002, 6 (Suppl) : S344.
4Lijnen P, Petrov V. Induction of cardiac fibrosis by aldosterone[J]. Mol Cell Cardiol,2000,32 (6):865.
5Nahrendorf M, Hu K, Hiller K H, et al. Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on leftventricular remodeling after myocardial infarction: an experimental serial cardiac magnetic resonance imaging study[J]. Am Coll Cardiol,2002, 40(9) :1695.
6Oi S, Haneda T, Osaki J, et al. Lovastatin prevents angiontensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells[J]. Eur J Pharmacol,1999,376(1-2) :139.
7Feldman A F, Combes A, Wagner D, et al. The role of tumor necrosis factor in the pathophysiology of heart failure[J]. Am Coll Cardiol, 2000, 35 (3) : 537.
8Mann D L. Recent in sights into the role of tumor necrosis factor in the failure heart[J]. Heart Fail, 2001, 6(2): 71.
